EICHOR ● Active Not Recruiting

Intra-operative Pancreatoscopy in Patients With IPMN

Condition: Intraductal Papillary Mucinous Neoplasm · Sponsor: Boston Scientific Corporation

PhaseN/A

Planned participants100

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

To demonstrate the added value of intraoperative pancreatoscopy in patients undergoing partial pancreatic resection for the treatment of Intraductal Papillary Mucinous Neoplasm (IPMN) as it pertains to detection of discontinuous (skip) lesions in the remnant pancreas; to generate a hypothesis for a subsequent randomized control trial.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (8)

University of Colorado Hospital	Denver, Colorado, United States	—
Indiana University Health	Indianapolis, Indiana, United States	—
Johns Hopkins Hospital University	Baltimore, Maryland, United States	—
The First Affiliated Hospital of Nanjing Medical University	Nanjing, China	—
Asian Institute of Gastroenterology	Hyderabad, India	—
Kansai Medical University	Hirakata, Osaka, Japan	—
Academic Medical Center	Amsterdam, Netherlands	—
University Hospital of UMEA	Umeå, Sweden	—

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →